Sustained Graft-Versus-Lymphoma Effect among Patients (pts) with Mantle Cell Lymphoma (MCL) Given Nonmyeloablative, Allogeneic Hematopoictic Cell Transplantation (HCT).

被引:0
作者
Sorror, Mohamed L.
Storer, Barry
Sandmaier, Brenda M.
Maris, Michael
Chauncey, Thomas [1 ]
Maziarz, Richard T. [2 ]
Pulsipher, Michael [3 ]
Shizuru, Judith [4 ]
Niederwieser, Dietger [5 ]
Agura, Edward [6 ]
Wade, James C. [7 ]
Langston, Amelia A. [8 ]
Storb, Rainer F.
Maloney, David G.
机构
[1] Univ Washington, Fred Hutchinson Canc Res Ctr, VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Univ Utah, Med Ctr, Salt Lake City, UT USA
[4] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[5] Univ Leipzig, Leipzig, Germany
[6] Baylor Univ, Med Ctr, Dallas, TX USA
[7] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[8] Emory Univ, Sch Med, Atlanta, GA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:747 / 748
页数:2
相关论文
共 50 条
[41]   Long-Term Sustained Disease Control in Patients With Mantle Cell Lymphoma With or Without Active Disease After Treatment With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning [J].
Vaughn, Jennifer E. ;
Sorror, Mohamed L. ;
Storer, Barry E. ;
Chauncey, Thomas R. ;
Pulsipher, Michael A. ;
Maziarz, Richard T. ;
Maris, Michael B. ;
Hari, Parameswaran ;
Laport, Ginna G. ;
Franke, Georg N. ;
Agura, Edward D. ;
Langston, Amelia A. ;
Rezvani, Andrew R. ;
Storb, Rainer ;
Sandmaier, Brenda M. ;
Maloney, David G. .
CANCER, 2015, 121 (20) :3709-3716
[42]   Nonablative allogeneic stem cell transplantation for relapsed mantle cell lymphoma (MCL): A promising strategy for an aggressive disease. [J].
Khouri, IF ;
Lee, MS ;
Saliba, RM ;
Gu, J ;
Fayad, L ;
Hosing, C ;
Donato, ML ;
Pro, B ;
Couriel, D ;
Rodriguez, M ;
Korbling, M ;
Cabanillas, F ;
Ruth, K ;
Champlin, R .
BLOOD, 2002, 100 (11) :426A-427A
[43]   Allogeneic transplantation for poor risk mantle cell lymphoma (MCL): Chemosensitivity predicts superior outcome. [J].
Khouri, IF ;
Saliba, RM ;
Younes, A ;
Acholonu, S ;
Andersson, B ;
Bibawi, S ;
de Lima, M ;
Fayad, L ;
Giralt, S ;
Hagemeister, FB ;
Korbling, M ;
Rodriguez, MA ;
Romaguera, J ;
Cabanillas, F ;
Champlin, RE .
BLOOD, 2001, 98 (11) :416A-416A
[44]   Impact of graft-versus-lymphoma effect on outcomes after reduced intensity conditioned-alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies [J].
Brierley, Charlotte K. ;
Jones, Francesca M. ;
Hanlon, Katharine ;
Peniket, Andy J. ;
Hatton, Chris ;
Collins, Graham P. ;
Schuh, Anna ;
Medd, Patrick ;
Clark, Andrew ;
Ward, Janice ;
Chaganti, Sridar ;
Malladi, Ram ;
Parker, Anne ;
Craddock, Charles ;
Danby, Robert ;
Rocha, Vanderson .
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (04) :547-557
[45]   OUTCOME OF PATIENTS WITH MANTLE CELL LYMPHOMA UNDERGOING AUTOLOGOUS VERSUS REDUCED-INTENSITY ALLOGENEIC TRANSPLANTATION [J].
Fenske, T. S. ;
Carreras, J. ;
Zhang, M. ;
Laport, G. G. ;
Montoto, S. ;
Maloney, D. G. ;
Hari, P. N. .
ANNALS OF ONCOLOGY, 2011, 22 :87-87
[46]   Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation [J].
Mamez, A. C. ;
Souchet, L. ;
Roos-Weil, D. ;
Uzunov, M. ;
Brun, A. L. ;
Algrin, C. ;
Leblond, V. ;
Nguyen, S. .
BONE MARROW TRANSPLANTATION, 2015, 50 (02) :304-306
[47]   Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation [J].
A C Mamez ;
L Souchet ;
D Roos-Weil ;
M Uzunov ;
A L Brun ;
C Algrin ;
V Leblond ;
S Nguyen .
Bone Marrow Transplantation, 2015, 50 :304-306
[48]   Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma [J].
Berdeja, JG ;
Jones, RJ ;
Zahurak, ML ;
Piantadosi, S ;
Abrams, RA ;
Borowitz, MJ ;
Vogelsang, GB ;
Noga, SJ ;
Ambinder, RF ;
Flinn, IW .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (10) :561-567
[49]   Nonmyeloablative allogeneic hematopoietic cell transplantation (HCT) for refractory Waldenstrom is macroglobulinemia (WM): Evidence for a graft-versus-WM effect. [J].
Anderson, Larry D., Jr. ;
Sandmaier, Brenda M. ;
Maris, Michael B. ;
Niederwieser, Dietger ;
Agura, Edward ;
Maziarz, Richard T. ;
Chauncey, Thomas R. ;
Storb, Rainer ;
Maloney, David G. .
BLOOD, 2006, 108 (11) :862A-862A
[50]   Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 Patients [J].
Lamm, Wolfgang ;
Wohlfarth, Philipp ;
Bojic, Marija ;
Schoergenhofer, Christian ;
Kalhs, Peter ;
Raderer, Markus ;
Rabitsch, Werner .
ONCOLOGY, 2015, 89 (02) :118-123